Acusphere Inc banner

内在价值

ACUS latest financial reports are more than 14 years old.
ACUS doesn't have a meaningful market cap.
暂无 ACUS 的相关数据

数据不足,无法可靠地计算 Acusphere Inc 的内在价值。

我们的估值真的有效吗? 查看回测结果 .

ACUS 的替代投资选择

基本面分析

Acusphere 做什么

制药 Health Care

Acusphere, Inc. is a pharmaceutical company, which engages in the development of drugs and formulations of existing drugs using proprietary micro particle technology. The company is headquartered in Lexington, Massachusetts. The company went IPO on 2003-10-08. The firm is focused on the development of Imagify, which contains Perflubutane Polymer Microspheres for injectable suspension. The firm's product Imagify is a cardiovascular drug for the detection of coronary artery disease (CAD).

总部
美国 US
上市日期
2003年10月8日
阅读完整公司概况
查看公司概况
财务数据
运营效率

利润瀑布图
Acusphere Inc

华尔街目标价

资本回报

回购收益率
尚未解锁
偿债收益率
尚未解锁

竞争格局